SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
81 hedge funds and large institutions have $177M invested in scPharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4.9% less ownership
Funds ownership: 83.47% → 78.57% (-4.9%)
17% less capital invested
Capital invested by funds: $213M → $177M (-$36.5M)
Holders
81
Holding in Top 10
2
Calls
$1.02M
Puts
$160K
Top Buyers
| 1 | +$8.26M | |
| 2 | +$5.64M | |
| 3 | +$4.93M | |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
+$4.12M |
| 5 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$2.87M |
Top Sellers
| 1 | -$23.5M | |
| 2 | -$12.8M | |
| 3 | -$5.99M | |
| 4 |
Morgan Stanley
New York
|
-$4.63M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.99M |